Feasibility studies are often the first attempt researchers use to test whether a new process or part of a process is practical for use in a clinical setting or a device will provide the desired information. When conducting a device feasibility study there are several unique considerations that must be addressed. This manuscript describes the processes and considerations.
. Feasibility studies are testing pieces of research. They answer the question, "Can this be done?" While pilot studies are a miniature test of an entire process. The intent of a feasibility study is to determine whether the protocol and planned procedures will work together (Bowen et al., 2009 ). In the case of the study example, we will first need to see whether electroencephalography (EEG) data derived from BIS monitors are valid and reliable for detecting delirium. As a result, we are examining whether it is feasible to use the equipment in the clinical environment for delirium monitoring. Therefore, our study is a feasibility study rather than a pilot study.
Prior to beginning a device study, it is important to assess and strengthen the environment by assisting stakeholders with realizing the potential benefits of this type of research (Bowen et al., 2009 ). In a feasibility study for testing a device, ease of recruitment must be assessed as well as acceptance by the nursing staff. Therefore, patients will need to be educated on the purpose of a novel device and the potential to improve clinical care, patient outcomes, and advance the standard of care. Each group of potential stakeholders will have their own set of motivators and ideas of benefits that will need to be considered by the researcher (Holmes et al., 2016) . There are advantages to using equipment already available in practice for a study. As with the example study, the BIS monitor is available for use in clinical practice but is used for monitoring sedation. As a result, such a study would not require additional Food and Drug Administration (FDA) approval (James, 2005) . This is because the device has already gone through initial clinical safety and device functionality evaluation. However, these studies can inform subsequent device modifications and future clinical study designs.
There may be cases where a researcher will have to seek FDA approval through an investigational device exemption (IDE; James, 2005) . The exemption application must be a joint endeavor between the manufacturer and the primary investigator's institution. The best approach is for the manufacturer to lead the request, as they are more accustomed to obtaining exemptions. Typically, manufacturers have more experience due to the nature of the business, developing devices. There is an application fee and a lengthy process. Researchers will need to allow time for this approval.
Benefit of Feasibility Studies
Benefits of participation are likely to provide the following:
1. Patients will gain earlier access to the device not available under the current circumstances. This may improve their own care or the care of others such as family and friends (Bowen et al., 2009; Holmes et al., 2016) .
2. Investigators benefit through access to devices. A feasibility study may inform device development or modifications. These studies are generally smaller and will cost less than a full study. It is important to have feasibility and pilot study work when preparing to apply for larger federal funding. 3. For the novice researcher, feasibility studies are a good first choice.
The sample typically is smaller; therefore, the volume of data is easier to manage. Feasibility studies provide an opportunity to test the protocol to determine whether what is being asked of researchers, the clinical site, and participants can realistically occur. Finally, these studies are generally not as expensive and easier for a novice to get funded. 4. Junior researchers may use this approach to test the feasibility of a study before moving into a larger one. The ability to identify issues prior to a pilot study will ensure a greater chance of success. 5. The study site from which participants are enrolled, receive education and training regarding pathology, patient care needs and an understanding of the concepts as well as the device. Depending on the facility, another potential benefit might be testing the research process and increase the likelihood of site participation for future studies. Studies conducted in Magnet ® -designated facilities may be more open to a feasibility study when devices are involved. 6. Funders of and investigators using the proposed device could have results that result in a patent or an algorithm that has the potential to make a substantial difference in patient outcomes. This is of course with pilot data and a randomized controlled trial. 7. Device developers and U.S.-based industry sponsors have several advantages when conducting research overseas. Such research can decrease cost substantially. Device studies provide an opportunity to connect with inventors and health care systems, to expand marketing of other products and devices. Finally, to be in on the ground level observing processes and data, a researcher may be involved with expediting a product for US consumption. 8. Institutional review board (IRB) members benefit through early exposure to new technologies. This has potential to make future IRB evaluations of device research proposals more efficient.
Potential Challenges in Execution
Legal and contractual processes vary from one facility to the next. Depending on the requirements and expectations of the clinical setting, this may affect timely initiation of the proposed research study. It is important to allow a reasonable amount of time to work through study logistics and details. If there is a potential risk to participants, the clinical site will need to develop a plan to handle potential challenges. The first and most pressing concern for the clinical site is the potential for injury of patients who would become research subjects as well as the cost of related treatment (Holmes et al., 2016) . Costs may be in the form of publicly reported metrics as well as associated treatment costs. In addition, depending on the agency and type of funding, sponsor support may result in termination and prevent completion. In the BIS study, the concern for injury is related to skin breakdown or irritation on the forehead because of electrodes and/or adhesive. For the facility, this could mean increased costs to treat the skin as well as threaten public reporting data. To address this issue, BIS electrodes should be removed at any point breakdown or irritation is detected and disenroll the participant in the study. IRB viewpoints and processes vary considerably from one facility to the next. When using a device off label (not for its intended purpose), there are unique considerations compared with other research (Holmes et al., 2016) . This is because of the unknown risks associated with using a device for a purpose other than its original intent. From our example of the BIS-EEG experience, use of the device and associated data collection may result in many months of delay. To address these concerns, modifications can be made in processes used for handling the EEG data. Such modifications may reduce the risk of confidentiality breaches. In addition, long review times can be impacted by IRB meeting frequency, requirements to have all legal and contractual agreements finalized prior to IRB approval and the ethical and philosophical approach of the IRB's institution.
Working With the IRB
The following consideration maybe be helpful when working with IRBs (James, 2005) .
1. Make sure the proposal and other documents are well organized and thorough. Remember, the IRB's purpose is to protect participants. It will also be pertinent to emphasis processes including who will implement the study to ensure informed consent as well as processes to prevent or reduce risk of injury. Patient identity protection and disclosure of private health information is always a concern for the IRB. Many IRBs have form templates for consent and other documents. It is best to search their website and make use of their document templates rather than developing new ones.
2. Consider additional personnel that may be beneficial to moving through the process. Adding site staff shows collaboration, facility commitment, and provides the research setting with opportunities not only to see protocols in detail but also to have a voice in protocol development. This will help minimize acceptance challenges later.
Risk to Research Participants
It is important to have clearly identified responsibility prior to initiation. Depending on the medical device, this may also include liability (Cseko & Tremaine, 2013; Holmes et al., 2016) . For example, in the BIS-EEG feasibility study design, consideration for an adhesive allergy and skin tears in older patients with fragile skin are potential risks. Protocols to address these risks must be addressed prior to moving forward with IRB review. Consideration for whether the site currently uses the device for its intended purpose will direct planning and implementation processes. Although BIS monitoring is used as a standard of care for sedation monitoring in some intensive care units (ICUs), it may not be standard of care in the study site. As a result, several meetings with unit nursing personnel and provider leadership are needed to discuss the study and potential risks. The clinical site may be more supportive in situations where patients are able to participate such as in a Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) assessment. For the clinical site, acceptance may be higher when the selected study exclusion criteria remove patients with higher acuity. Therefore, greater risk would be excluded.
Older adults (>65 years) requiring mechanical ventilation in an ICU are considered a vulnerable population (Cseko & Tremaine, 2013) . As a result, some advanced planning would be required prior to submitting a proposal to both the clinical site and the IRB. Some examples of things to consider are who will be responsible for consenting subjects and will patients who regain capacity to self-consent be consented during the study. Having a legally authorized representative (LAR) provide consent for patients lacking capacity should be considered (Cseko & Tremaine, 2013) . In addition, each day, a patient or LAR permission should be ascertained to ensure willingness to continue participation.
As with any study, compliance with the study protocol and implementation are always a concern. When medical devices are involved, the additional concern will be whether to use the facility equipment or purchase research-only equipment for the study (Holmes et al., 2016) . If research equipment is provided, it will be important to consider processes for clinical site approval to use the device, cleaning and tracking the equipment. If facility equipment is used, there is a potential threat the device may be needed to provide patient care elsewhere in the facility. This would result in removal of the device from a research patient to meet that need.
In the case of the BIS monitor example, the facility should have their Biomedical Engineering team approve each monitor prior to use in the clinical area. The BIS monitors should be stored on the unit in a badge access storage closest and, when in use, be mounted to a dedicated pole with a bright label stating "for research only." Because the facility periodically uses BIS monitors in the unit, it would be very important to stress that fact, along with justification when attempting to obtain funding. Finally, another concern is addressing a plan for any missing data.
Conducting a Device Feasibility Study
Site selection is a crucial aspect of study design (Bowen et al., 2009 ). Evidence of strong commitment and leadership to support the research is important. If the facility has a department or center for research within the setting, this is a strong indicator of potential commitment. When discussing a particular study, it is also important to determine whether the facility has the volume of patients to meet the inclusion criteria. The infrastructure should give some inkling regarding the potential participant pool. In the case of the BIS study, one would check the medical and surgical ICUs for an average daily census to ensure there are ample critical care patients to participate. Also, the researcher should investigate the skill mix and patient demographics in the proposed study units. Length of stay for each setting will be needed to ensure the potential participants meeting inclusion criteria would be in the unit long enough to obtain the amount of data required for the study.
The facility will be concerned about additional staff workload required to complete the study (Holmes et al., 2016) . Therefore, it is important to consider how much additional work is being asked of the facility. If the increase in work is too high, they may feel unable to meet the needs of the research being proposed and decline participation. Keeping workload to the a minimum to complete the research should be a priority when designing the study. If there is significant effort expected of facility staff, consider funding to cover associated costs as an incentive for the clinical site. In the case of this study example, the research team would complete most of the work such as, completing CAM-ICU assessments, initiating application of the monitor, removal of the monitor at conclusion of participant participation, and the cleaning process for equipment. The nursing staff will need to monitor the patient's skin and re-apply leads when the research team is not present, thereby reducing site workload to a minimum.
Training and Education
During the design phase, it is important to consider what training will be required for both the research team and the facility staff (Holmes et al., 2016) . Inquiry regarding whether the selected facility currently uses the device and how frequently will also be important. However, even if the staff are fluent with the device, it is important to provide a refresher course and describe use in the study. If the facility does not regularly use the device, more training will be required. Because delirium is frequently considered an expected consequence of being in the unit with a critical illness, it will also be important to provide education on the phenomena of interest such as delirium. This education would include the pathophysiology driving the research. In addition, how the device will improve delirium identification, potential benefits to patients and staff and the impact on patient outcomes would need to be discussed.
Conclusion
Investigating the potential expanded uses of medical devices is important. Improving early access to device use may improve care. Feasibility studies allow for testing of processes involved and possible challenges such as recruitment, acceptance of use, and other logistics for implementation. When planning and designing a study, all the stakeholders should be at the table to allow plenty of time for development and IRB processes. Finally, completing a feasibility study will not only help improve opportunities for larger studies and funding but also, more importantly, allow for identification of processes that need to be redesigned.
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